Medpace MEDP Stock
Medpace Price Chart
Medpace MEDP Financial and Trading Overview
| Medpace stock price | 380.05 USD |
| Previous Close | 218.3 USD |
| Open | 217.95 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 214.35 - 222.07 USD |
| 52 Week Range | 130.79 - 241.48 USD |
| Volume | 349.26K USD |
| Avg. Volume | 338.47K USD |
| Market Cap | 6.73B USD |
| Beta (5Y Monthly) | 1.416901 |
| PE Ratio (TTM) | 27.714825 |
| EPS (TTM) | 8.89 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 224.75 USD |
MEDP Valuation Measures
| Enterprise Value | 6.96B USD |
| Trailing P/E | 27.714825 |
| Forward P/E | 23.594652 |
| PEG Ratio (5 yr expected) | 1.9 |
| Price/Sales (ttm) | 4.304464 |
| Price/Book (mrq) | 19.409643 |
| Enterprise Value/Revenue | 4.452 |
| Enterprise Value/EBITDA | 21.484 |
Trading Information
Medpace Stock Price History
| Beta (5Y Monthly) | 1.416901 |
| 52-Week Change | 62.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 241.48 USD |
| 52 Week Low | 130.79 USD |
| 50-Day Moving Average | 204.58 USD |
| 200-Day Moving Average | 197.68 USD |
MEDP Share Statistics
| Avg. Volume (3 month) | 338.47K USD |
| Avg. Daily Volume (10-Days) | 381.82K USD |
| Shares Outstanding | 30.5M |
| Float | 23.37M |
| Short Ratio | 7.83 |
| % Held by Insiders | 45.27% |
| % Held by Institutions | 82.12% |
| Shares Short | 1.98M |
| Short % of Float | 9.89% |
| Short % of Shares Outstanding | 6.48% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 16.43% |
| Operating Margin (ttm) | 19.23% |
| Gross Margin | 64.14% |
| EBITDA Margin | 20.72% |
Management Effectiveness
| Return on Assets (ttm) | 13.71% |
| Return on Equity (ttm) | 53.96% |
Income Statement
| Revenue (ttm) | 1.56B USD |
| Revenue Per Share (ttm) | 49.76 USD |
| Quarterly Revenue Growth (yoy) | 31.19% |
| Gross Profit (ttm) | 925.11M USD |
| EBITDA | 323.89M USD |
| Net Income Avi to Common (ttm) | 256.78M USD |
| Diluted EPS (ttm) | 7.96 |
| Quarterly Earnings Growth (yoy) | 18.89% |
Balance Sheet
| Total Cash (mrq) | 46.92M USD |
| Total Cash Per Share (mrq) | 1.54 USD |
| Total Debt (mrq) | 276.93M USD |
| Total Debt/Equity (mrq) | 79.75 USD |
| Current Ratio (mrq) | 0.417 |
| Book Value Per Share (mrq) | 11.366 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 421.87M USD |
| Levered Free Cash Flow (ttm) | 333.19M USD |
Profile of Medpace
| Country | United States |
| State | OH |
| City | Cincinnati |
| Address | 5375 Medpace Way |
| ZIP | 45227 |
| Phone | 513 579 9911 |
| Website | https://www.medpace.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 5400 |
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Q&A For Medpace Stock
What is a current MEDP stock price?
Medpace MEDP stock price today per share is 380.05 USD.
How to purchase Medpace stock?
You can buy MEDP shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medpace?
The stock symbol or ticker of Medpace is MEDP.
Which industry does the Medpace company belong to?
The Medpace industry is Diagnostics & Research.
How many shares does Medpace have in circulation?
The max supply of Medpace shares is 32.2M.
What is Medpace Price to Earnings Ratio (PE Ratio)?
Medpace PE Ratio is 44.43194600 now.
What was Medpace earnings per share over the trailing 12 months (TTM)?
Medpace EPS is 8.89 USD over the trailing 12 months.
Which sector does the Medpace company belong to?
The Medpace sector is Healthcare.
Medpace MEDP included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Horizon Kinetics ISE Wealth Ind RCH | 3156.06 USD — |
-1.84
|
— — | 3147.26 USD — | 3200.92 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Global Buyback Achievers DRBG | 2057.38 USD — |
-0.89
|
— — | 2057.25 USD — | 2057.65 USD — | — - | — — |
| Nasdaq US Smart Pharmaceuticals NQSSPH | 1383.38 USD — |
-2.07
|
— — | 1380.57 USD — | 1408.57 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2541.54 USD — |
-1.89
|
— — | 2531.95 USD — | 2572.66 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ US Buyback Achievers Sel DRBS | 2224.13 USD — |
-1.64
|
— — | 2217.6 USD — | 2253.41 USD — | — - | — — |
- {{ link.label }} {{link}}